These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9621276)

  • 21. Hypoxia-inducible factor-1α (HIF-1α) and autophagy in polycystic kidney disease (PKD).
    Belibi F; Zafar I; Ravichandran K; Segvic AB; Jani A; Ljubanovic DG; Edelstein CL
    Am J Physiol Renal Physiol; 2011 May; 300(5):F1235-43. PubMed ID: 21270095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Endothelin system in polycystic kidneys of Han:SPRD rats.
    Hocher B; Zart R; Braun N; Schwarz A; van der Woude F; Rohmeiss P; Koppenhagen K
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S342-4. PubMed ID: 9595476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What is the role of tubular epithelial cell apoptosis in polycystic kidney disease (PKD)?
    Edelstein CL
    Cell Cycle; 2005 Nov; 4(11):1550-4. PubMed ID: 16258272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of paclitaxel on the progression of polycystic kidney disease in rodents.
    Martinez JR; Cowley BD; Gattone VH; Nagao S; Yamaguchi T; Kaneta S; Takahashi H; Grantham JJ
    Am J Kidney Dis; 1997 Mar; 29(3):435-44. PubMed ID: 9041221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Focal overexpression of collagen IV characterizes the initiation of epithelial changes in polycystic kidney disease.
    Schäfer K; Bader M; Gretz N; Oberbäumer I; Bachmann S
    Exp Nephrol; 1994; 2(3):190-5. PubMed ID: 7922272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracellular matrix, integrins, and focal adhesion signaling in polycystic kidney disease.
    Zhang Y; Reif G; Wallace DP
    Cell Signal; 2020 Aug; 72():109646. PubMed ID: 32311505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autosomal-dominant polycystic kidney disease in the rat.
    Cowley BD; Gudapaty S; Kraybill AL; Barash BD; Harding MA; Calvet JP; Gattone VH
    Kidney Int; 1993 Mar; 43(3):522-34. PubMed ID: 8455352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global gene expression profiling in early-stage polycystic kidney disease in the Han:SPRD Cy rat identifies a role for RXR signaling.
    Kugita M; Nishii K; Morita M; Yoshihara D; Kowa-Sugiyama H; Yamada K; Yamaguchi T; Wallace DP; Calvet JP; Kurahashi H; Nagao S
    Am J Physiol Renal Physiol; 2011 Jan; 300(1):F177-88. PubMed ID: 20926632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease.
    Tao Y; Kim J; Schrier RW; Edelstein CL
    J Am Soc Nephrol; 2005 Jan; 16(1):46-51. PubMed ID: 15563559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered organic anion and osmolyte content and excretion in rat polycystic kidney disease: an NMR study.
    Ogbron MR; Sareen S; Prychitko J; Buist R; Peeling J
    Am J Physiol; 1997 Jan; 272(1 Pt 2):F63-9. PubMed ID: 9039050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease.
    Nagao S; Yamaguchi T; Kusaka M; Maser RL; Takahashi H; Cowley BD; Grantham JJ
    Kidney Int; 2003 Feb; 63(2):427-37. PubMed ID: 12631108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation and cell polarity during renal cyst formation in the Han:SPRD (cy/+) rat, a model for ADPKD.
    Obermüller N; Gretz N; Kriz W; van der Woude FJ; Reilly RF; Murer H; Biber J; Witzgall R
    Am J Physiol; 1997 Sep; 273(3 Pt 2):F357-71. PubMed ID: 9321908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary soy protein effects on disease and IGF-I in male and female Han:SPRD-cy rats.
    Aukema HM; Housini I
    Kidney Int; 2001 Jan; 59(1):52-61. PubMed ID: 11135057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gender and the effect of gonadal hormones on the progression of inherited polycystic kidney disease in rats.
    Cowley BD; Rupp JC; Muessel MJ; Gattone VH
    Am J Kidney Dis; 1997 Feb; 29(2):265-72. PubMed ID: 9016899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Androgen receptor pathway in rats with autosomal dominant polycystic kidney disease.
    Nagao S; Kusaka M; Nishii K; Marunouchi T; Kurahashi H; Takahashi H; Grantham J
    J Am Soc Nephrol; 2005 Jul; 16(7):2052-62. PubMed ID: 15888569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor κB-induced inflammation.
    Wu M; Gu J; Mei S; Xu D; Jing Y; Yao Q; Chen M; Yang M; Chen S; Yang B; Qi N; Hu H; Wüthrich RP; Mei C
    Nephrol Dial Transplant; 2016 Nov; 31(11):1826-1834. PubMed ID: 27190325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary biomarkers for monitoring disease progression in the Han:SPRD-cy rat model of autosomal-dominant polycystic kidney disease.
    Wiedmeyer CE; Royal AB
    Comp Med; 2010 Dec; 60(6):448-54. PubMed ID: 21262131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pathogenesis of polycystic kidney disease.
    Carone FA; Bacallao R; Kanwar YS
    Histol Histopathol; 1995 Jan; 10(1):213-21. PubMed ID: 7756739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hereditary error in epidermal growth factor prohormone metabolism in a rat model of autosomal dominant polycystic kidney disease.
    Lakshmanan J; Eysselein V
    Biochem Biophys Res Commun; 1993 Dec; 197(3):1083-93. PubMed ID: 8280123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).
    Wahl PR; Serra AL; Le Hir M; Molle KD; Hall MN; Wüthrich RP
    Nephrol Dial Transplant; 2006 Mar; 21(3):598-604. PubMed ID: 16221708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.